BSX Boston Scientific Corporation
Healthcare$57.78+1.10%ClosedMarket Cap: $85.88B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$91.17
Target (Median)
$90.00
Target Range
$60.00 - $120.00
Upside from current price: 57.8%
Rating Distribution
9 Strong Buy23 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-19 | Baird | maintain | Outperform | Outperform |
| 2026-05-18 | BTIG | maintain | Buy | Buy |
| 2026-05-18 | Needham | maintain | Buy | Buy |
| 2026-05-18 | B of A Securities | maintain | Buy | Buy |
| 2026-04-23 | RBC Capital | maintain | Outperform | Outperform |
| 2026-04-23 | Barclays | maintain | Overweight | Overweight |
| 2026-04-23 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-04-23 | Truist Securities | maintain | Buy | Buy |
| 2026-04-23 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-04-23 | Goldman Sachs | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $3.77 | $23.56B | 18 |
| Sun Dec 31 | $4.23 | $25.64B | 9 |
| Mon Dec 31 | $4.82 | $28.53B | 3 |
| Tue Dec 31 | $5.31 | $31.32B | 3 |